Affiliation:
1. Department of Psychosis Studies, King’s College London, King’s Health Partners, Institute of Psychiatry, London SE5 8AF, UK
Abstract
Although the genetic contribution to schizophrenia pathogenesis has been well established, with an approximate heritability of 81%, the endeavor to elucidate the complex genetic architecture of schizophrenia has met limited success. ‘Endophenotypes’, or ‘intermediate phenotypes’, are more restricted constructs of genetic risk than the clinical manifestations hitherto employed by molecular geneticists. They are, putatively, intermediate in the pathophysiological pathway between genetic variation and clinical phenomenology and can possibly be used to assist in the elucidation of genetic diathesis for schizophrenia. In this article, we present the current evidence that supports functional MRI parameters as promising candidate endophenotypes in schizophrenia.
Subject
Clinical Neurology,Neurology
Reference150 articles.
1. American Psychiatric Association (APA):Diagnostic and Statistical Manual of Mental Disorders, 4th Edition.American Psychiatric Press, Washington, DC, USA (1994).
2. WHO.The ICD-10 Classification of Mental and Behavioral Disorders: Diagnostic Criteria for Research.WHO, Geneva, Switzerland (1993).
3. RitsnerMS, Gottesman II: Where do we stand in the quest for neuropsychiatric biomarkers and what next? In:The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes, Volume 1: Neuropsychological Endophenotypes and Biomarkers.Ritsner MS (Ed.). Springer, NY, USA,3–17 (2009).
4. Biomarkers in psychiatry: drawbacks and potential for misuse
5. Schizophrenia: From the brain to peripheral markers. A consensus paper of the WFSBP task force on biological markers
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献